TEMPRA PED 100 MG 30ML GTS SITAGLIPTINA Tratamiento de embolia pulmonar (EP)

Description

Tratamiento de embolia pulmonar (EP)

DOSIS: 15 ML

PRINCIPIO ACTIVO: CLINDAMICINA

un agente antineoplásico indicado para el tratamiento de tumores cerebrales malignos

FABRICANTE: MAVER

TEMPRA PED 100 MG 30ML GTS SITAGLIPTINA Tratamiento de embolia pulmonar (EP)PRINCIPIO ACTIVO: PARACETAMOL

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy